Comparing the Pain Experience Between Patients Who Have and Who Have Not Undergone Dermatologic Procedures
- Conditions
- Pain
- Interventions
- Device: ThermageOther: Needle ApplicationDevice: VBeam LaserDevice: Ulthera
- Registration Number
- NCT01285947
- Lead Sponsor
- Northwestern University
- Brief Summary
The purpose of this study is to compare the pain experience of patients who have not had dermatologic procedures (previously "unexposed") using energy devices (lasers, radiofrequency, ultrasound, etc.) with patients who have previously had procedures (previously "exposed") using energy devices. Based on previous clinical encounters, individuals with no prior experience with cosmetic procedures appear to experience more pain. However, no study to date has thoroughly examined this observation. As a result, this study has been designed to find a possible difference in pain perception between previously exposed and unexposed patients undergoing cosmetic procedures using energy devices.
- Detailed Description
Twenty subjects will be enrolled in the study: 10 subjects who have had cosmetic procedures in the past and 10 subjects who have not had such procedures. For each subject, pain tolerance in three areas will be assessed: temple, midface/cheek, and abdomen. In two areas of the face (temple and midface/cheek), a small sterile needle will be inserted into the skin along with three applications of the following devices that are FDA approved for use on the face: an ultrasound device (Ulthera), a pulsed dye laser (VBeam), and a radiofrequency (Thermage) device. Additionally, the abdomen will receive three of these four devices in a randomized order: small sterile needle insertion, a pulsed dye laser (VBeam) pulse, and a radiofrequency (Thermage) exposure (the ultrasound device, Ulthera, will not be used on the abdomen because it is currently not FDA approved for this indication). Subjects will then be asked to rate their pain after each application at each individual site using a pain scale. In addition, subjects will complete a questionnaire regarding their pain experiences and other possibly related factors before and after the procedures.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Not provided
- Subjects who have an active skin disease or skin infection in or around the treatment.
- Subjects who are unable to understand the protocol or give informed consent.
- Subjects with photophobia or who are unable to tolerate the treatments.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Non-Naive Subjects Needle Application Subjects who have previously undergone energy-based dermatologic procedures in the past. Naive Subjects Ulthera Subjects who have not previously undergone energy-based dermatologic procedures in the past. Naive Subjects VBeam Laser Subjects who have not previously undergone energy-based dermatologic procedures in the past. Naive Subjects Needle Application Subjects who have not previously undergone energy-based dermatologic procedures in the past. Non-Naive Subjects Ulthera Subjects who have previously undergone energy-based dermatologic procedures in the past. Naive Subjects Thermage Subjects who have not previously undergone energy-based dermatologic procedures in the past. Non-Naive Subjects Thermage Subjects who have previously undergone energy-based dermatologic procedures in the past. Non-Naive Subjects VBeam Laser Subjects who have previously undergone energy-based dermatologic procedures in the past.
- Primary Outcome Measures
Name Time Method Pain Rated by Subjects 3 hours for all treatments in one visit The mean pain scores will be compared between naïve subjects and non-naïve subjects averaged over the anatomical sites: periocular (temple), midface/cheek, and abdomen and over all the different treatments.
Pain scores were recorded along a Visual Analog Scale (VAS) with 0 (no pain- better) to 10 (maximal pain-worst). This is a 10 cm long line in which the subject was asked to draw a line on the scale with 0 (no pain- better) at one end to 10 (maximal pain-worst) at the other end. The drawn line was measured on the 10 cm line using a ruler to obtain the score.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Northwestern University Department of Dermatology
🇺🇸Chicago, Illinois, United States